Symbol: |
P2RX5
|
Description: |
purinergic receptor P2X, ligand-gated ion channel, 5 [Source:HGNC Symbol;Acc:8536]
|
Location: |
Chr17:3575748-3599698[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:232
Gene |
Compound |
Gen_sig |
Exp_pattern |
P2RX5 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.019 |
Down |
P2RX5 |
3-Deazaneplanocin, hydrochloride |
0.021 |
Down |
P2RX5 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.01 |
Up |
P2RX5 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.003 |
Up |
P2RX5 |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.018 |
Down |
P2RX5 |
NSC 62349 |
0.021 |
Up |
P2RX5 |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.028 |
Down |
P2RX5 |
ANTINEOPLASTIC-625543 |
0.002 |
Down |
P2RX5 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.03 |
Up |
P2RX5 |
9-AMINO-20-CAMPTOTHECIN |
0.034 |
Down |
P2RX5 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.024 |
Up |
P2RX5 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.007 |
Up |
P2RX5 |
NSC 634398 |
0.013 |
Up |
P2RX5 |
NSC 637128 |
0.01 |
Down |
P2RX5 |
Dichlorobis[1-(4-nitrophenyl)-3-phenylpropane-1,3-dionato]-titanium(IV) |
0.034 |
Down |
Expression pattern: Sensitivity / Resistance
Total:16 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:9
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:70
Total:5 Current:1
[First] [Prev]  Next Last 
|